Zu Produktinformationen springen
1 von 1
Mariam T. Tennoe

Muromonab-CD3

Muromonab-CD3

Normaler Preis €136,00
Normaler Preis Verkaufspreis €136,00
Sale Ausverkauft
inkl. MwSt.
Zustand

Produktbeschreibung

Please note that the content of this book primarily consists of articlesavailable from Wikipedia or other free sources online. Muromonab-CD3(trade name Orthoclone OKT3, marketed by Janssen-Cilag) is animmunosuppressant drug given to reduce acute rejection in patients withorgan transplants. It is a monoclonal antibody targeted at the CD3receptor, a membrane protein on the surface of T cells. It was the firstmonoclonal antibody to be approved for clinical use in humans.Muromonab-CD3 was approved by the U.S. Food and Drug Administration(FDA) in 1986, making it the first monoclonal antibody to be used as adrug for humans worldwide. In the European Communities, it was the firstdrug to be approved under the directive 87/22/EWG, a precursor of theEuropean Medicines Agency (EMEA) centralised approval system in theEuropean Union. This process included an assessment by the Committee forProprietary Medicinal Products (CPMP, now CHMP), and a subsequentapproval by the national health agencies; in Germany, for example, in1988 by the Paul Ehrlich Institute in Frankfurt.

Produktdetails

  • ISBN-13: 9786133024533
  • ISBN-10: 6133024534
  • ASIN: 6133024534
Vollständige Details anzeigen Informationen anzeigen
1 von 3